Search clinical trials for: ESBL

Total 88 results

Region Skane
Lund University

Not yet recruiting

Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient

Multi-antibiotic Resistance
Beneficência Portuguesa de São Paulo
Merck Sharp & Dohme LLC

Not yet recruiting

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens (CLEMENT)

Febrile Neutropenia

Brazil
José Raimundo Araujo de Azevedo

Not yet recruiting

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Antimicrobial Resistance
Helsinki University Central Hospital
University of Helsinki

Recruiting

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections (FMT-UTI)

Recurrent Urinary Tract Infection

Finland
Emory University
Centers for Disease Control and Prevention

Not yet recruiting

Further MT for AntIbiotic-Resistant Bacterial Colonization in Inpatients (FAIR)

Multi-drug Resistant Organism

United States
Tourcoing Hospital

Recruiting

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU (BLSE-REA)

Drug Resistance, Multiple, Bacterial

France
Centre Hospitalier Régional Metz-Thionville

Recruiting

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit (Ger-SP)

Infection, Hospital

France
Lund University

Recruiting

Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs (PACUTI)

Bacteremia | Urinary Tract Infections | Antibiotic Resistant Infection

Sweden
Institut Pasteur
Institut Pasteur de Madagascar; Centre hospitalier de référence du District...

Recruiting

Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC (NeoLIC)

Enterobacteriaceae Infections

Madagascar
Fondation Hôpital Saint-Joseph

Recruiting

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient? (COPROBLSE2)

Enterobacteria Infections

France
Hospital Clinic of Barcelona
Fondo de Investigacion Sanitaria; Fundacion Clinic per a la Recerca Biomédica; Institut d'Investigacions Biomèdiques August Pi i Sunyer

Recruiting

Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL) (PROFTMDECOL)

CARRIER STATE

Spain
University Hospital, Bordeaux

Recruiting

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. (PROBATAZO)

Enterobacteriaceae Infections

France
University Hospital, Basel, Switzerland

Recruiting

Transmission of ESBL-producing Enterobacteriaceae

Hospital Acquired Infection

Switzerland
Western Galilee Hospital-Nahariya

Recruiting

Extended-spectrum β-lactamase -Producing Enterobacteriaceae (ESBL) Vertical Transmission in Women With Preterm Labor Versus Those in Term Pregnancy

Preterm Labor

Israel
Emory University
Centers for Disease Control and Prevention

Completed

Sentinel Cohort REACT

Multi-Drug Resistant Organism

United States
University Hospital, Akershus
Oslo University Hospital; Helse Stavanger HF; Sorlandet Hospital HF; Sykehuset... and other collaborators

Terminated

Fecal ESBL Resurgence During Antibiotic Treatment

Antibiotic Drug Resistance
Haydom Lutheran Hospital
University of Bergen; Helse Stavanger HF; Muhimbili University of Health and... and other collaborators

Active, not recruiting

Use of Probiotics to Reduce Infections, Death and ESBL Colonisation (ProRIDE)

Neonatal Sepsis

Tanzania
Hamad Medical Corporation

Completed

Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants (ABCUCEOI)

Renal Insufficiency

Qatar
University Hospital, Basel, Switzerland

Enrolling by invitation

Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli (PFGE-WGS)

Analysis Transmission Rate

Switzerland
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure (PoKES2_HYDRES)

Klebsiella Infections

France
Assistance Publique - Hôpitaux de Paris

Completed

Temocillin in ESBL-Enterobacteriaceae Infections (TMO2016)

Infectious Disease

France
The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
University Hospital, Basel, Switzerland
Gebert Rüf-Stiftung

Active, not recruiting

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Extended Spectrum Beta Lactamases (ESBL) E. Coli

Switzerland
Duke University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli (SHREC)

E Coli Infection

United States
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Paris Saint Joseph; French National Network of Clinical...

Completed

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections (TEMO-CARB)

Urinary Tract Infections

France
Kaleido Biosciences

Terminated

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms (VITORA)

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

United States
The Interregional Association for Clinical Microbiology...

Completed

In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram "-" Pathogens Isolated in Russia

Nosocomial Infection

Russian Federation
Centre Hospitalier Annecy Genevois
Hopital Foch; APHP; Sorbonne University; Hopitaux Civils de Colmar; CH Annecy Genevois

Completed

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae (TEMO-BLSE)

Urinary Tract Infection Bacterial
Assistance Publique - Hôpitaux de Paris
Direction Générale de l'Offre de Soins

Completed

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE) (CODBAHRE)

Risk Factor

France
Military Institute of Medicine, Poland

Unknown

"Peri-operative Antimicrobial Prophylaxis in Patients With Asymptomatic Bacteriuria of Enterobacteriacae ESBL+ Origin" (ESBL)

Asymptomatic Bacteriuria | Antimicrobial Prophylaxis

Poland
University Hospital, Angers

Unknown

Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).

ESBL-producing Enterobacteriaceae Infections
Institut de Médecine et d'Epidémiologie Appliquée...
ANRS, Emerging Infectious Diseases

Unknown

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs (BMR-IST)

HIV Infections | Bacterial Infections

France
University of Bordeaux

Unknown

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection (Microbe)

Critical Illness | Microbial Colonization | Extended Spectrum Beta-Lactamase Producing Bacteria Infection

France
Tan Tock Seng Hospital
Mayo Clinic

Unknown

Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) (RABbIT)

Sepsis | Fungemia | Bacteremia | Blood Stream Infection

Singapore
Venus Remedies Limited

Completed

CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (PLEA)

Acute Pyelonephritis | Urinary Tract Infection Complicated

India
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Completed

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli (FOREST)

Infection Due to ESBL Escherichia Coli

Spain
Lund University

Completed

ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

Traveler's Diarrhea | Antibiotic Resistant Infection | Antibiotic Resistant Strain

Sweden
Lund University

Completed

Can Probiotic Vivomixx Eradicate Colonization With ESBL?

Antibiotic Resistant Infection

Sweden
Universidad del Norte

Unknown

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

Urinary Tract Infections | Enterobacteriaceae Infections | Clinical Trial | Carbapenem | Klebsiella Pneumoniae Infection | Infection Due to ESBL Bacteria | Escherichia Coli Infection | Drug Resistance, Bacterial

Colombia
Nantes University Hospital

Completed

Prevalence of ESBL and CPE in French Nursing Homes (CARBEHPAD)

Enterobacteriaceae Infections

France
Spanish Network for Research in Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (INCREMENT-SOT)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Bacterial Infections | Bacteremia | Infection | Organ Transplantation | Clinically Significant Bacteremia

Spain
Centre Hospitalier Universitaire de Besancon

Unknown

Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM) (FOSF'HOM)

Urinary Tract Infections

France
Centre Hospitalier Universitaire de Besancon

Completed

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes. (R'EHPAD)

Drug Resistance, Bacterial

France
University of Tartu
Estonian University of Life Sciences

Unknown

Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals) (ABRESIST)

Methicillin Resistant Staphylococcus Aureus (MRSA) | Vancomycin (Glycopeptide) Resistant Enterococcus (VRE) | ESBL Producing E.Coli | ESBL Producing K.Pneumoniae | Multidrug Resistant P.Aeruginosa | Carbapenem Resistant P.Aeruginosa
University of Latvia
Latvian Biomedical Research and Study Centre

Enrolling by invitation

Effects of H.Pylori Eradication on Microbiome

Human Microbiome

Latvia
Centre Hospitalier Universitaire de Nice

Completed

Evaluation of Therapeutic Management in ESBL-infected Patients or Carriers by Providing and Sharing a Free Tool - the "ESBL toolKIT"and Interventional Study of a Prospective Cohort of HIV+ Patients Searching for Possible Sexual Transmission Factors in ESBL Carriers (Calires)

AIDS Patients

France
University Hospital, Basel, Switzerland
Stiftung Forschung Infektionskrankheiten, Basel, Switzerland

Completed

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Group B Streptococcal Infection | Infection Due to ESBL Bacteria

Switzerland
University of Pittsburgh

Completed

Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

Infection | ESBL | Quinolone Resistance | Klebsiella Species

United States
University of Pittsburgh

Completed

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Enterobacteriaceae Infections

United States

Search clinical trials for: ESBL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations